|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.45 INR | +1.95% |
|
+10.29% | +74.50% |
| May. 21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| May. 20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.72B 69.76M 60.96M 56.25M 51.85M 97.73M 99.9M 672M 264M 3.29B 262M 256M 11.33B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.58B 78.72M 68.79M 63.48M 58.51M 110M 113M 759M 298M 3.71B 296M 289M 12.78B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.79% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | +1.95% | ||
| 1 week | +10.29% | ||
| Current month | +0.93% | ||
| 1 month | +10.04% | ||
| 3 months | +57.36% | ||
| 6 months | +58.02% | ||
| Current year | +74.50% |
| 1 week | 111.5 | 125.5 | |
| 1 month | 111.5 | 133.95 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.95% | +10.29% | +5.51% | +2.20% | 69.76M | ||
| -0.90% | -0.15% | +14.11% | +81.10% | 48.15B | ||
| -0.23% | -1.65% | +67.15% | +112.03% | 35.59B | ||
| -0.76% | -1.44% | -4.29% | +37.63% | 11.9B | ||
| -0.88% | -0.62% | +17.31% | +89.97% | 11.85B | ||
| +0.19% | +2.87% | +34.92% | +139.73% | 9.31B | ||
| +3.37% | -0.10% | +51.64% | -3.75% | 7.02B | ||
| -0.75% | -0.91% | +17.45% | +37.70% | 6.91B | ||
| -2.25% | -2.08% | +0.45% | +209.99% | 6.55B | ||
| -9.93% | +0.35% | -31.51% | +16.58% | 6.13B | ||
| Average | -1.02% | +1.09% | +17.27% | +72.32% | 14.35B | |
| Weighted average by Cap. | -0.88% | -0.42% | +26.78% | +86.55% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.37M 34.4M 31.75M 29.26M 55.16M 56.38M 379M 149M 1.86B 148M 145M 6.39B | 3.74B 38.88M 33.98M 31.35M 28.9M 54.47M 55.68M 375M 147M 1.83B 146M 143M 6.31B |
| Net income | 122M 1.26M 1.1M 1.02M 939K 1.77M 1.81M 12.18M 4.79M 59.58M 4.74M 4.64M 205M | 58.38M 606K 530K 489K 451K 849K 868K 5.84M 2.3M 28.59M 2.28M 2.23M 98.43M |
| Net Debt | 1.16B 12.02M 10.51M 9.69M 8.94M 16.84M 17.22M 116M 45.57M 567M 45.14M 44.15M 1.95B | 863M 8.96M 7.83M 7.23M 6.66M 12.56M 12.83M 86.38M 33.98M 423M 33.66M 32.92M 1.46B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | ₹125.45 | +1.95% | 8,530 |
| 26-07-16 | ₹123.05 | +1.99% | 3,069 |
| 26-07-15 | ₹120.65 | +1.99% | 5,681 |
| 26-07-14 | ₹118.30 | +1.98% | 2,646 |
| 26-07-13 | ₹116.00 | +1.98% | 3,031 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















